To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dietary Hyaluronan, Glucosamine, and Chondroitin Mix for Moderate Pain from Knee Osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
November 2021

Dietary Hyaluronan, Glucosamine, and Chondroitin Mix for Moderate Pain from Knee Osteoarthritis

Vol: 141| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Liquid combination of hyaluronan, glucosamine, and chondroitin as a dietary supplement for knee osteoarthritis patients with moderate knee pain: A randomized controlled study

Medicine (Baltimore). 2021 Oct 8;100(40): e27405.

Contributing Authors:
SJ Wang YH Wang LC Huang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-seven patients reporting moderate pain from knee osteoarthritis were randomized to receive 8 weeks of daily dietary supplementation with a oral mixture of hyaluronic acid, glucosamine, and chondroitin (n=47) or an oral placebo (n=50). The primary outcome of interest was the change from baseline in Knee Injury and Osteoarthritis Outcomes Scores (KOOS). Secondary outcomes of interest included...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue